Bangkok Dusit Medical Services Public Company Limited
Bangkok Dusit Medical Services Public Company Limited (BDULF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Bangkok Dusit Medical Services Public Company Limited (BDULF), featuring income statements, balance sheets, and cash flow data.
Bangkok Dusit Medical Services Public Company Limited (BDULF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Bangkok Dusit Medical Services Public Company Limited BDULF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $28.08B | $27.40B | $28.15B | $25.70B |
| Cost of Revenue | $17.69B | $17.04B | $17.63B | $16.66B |
| Gross Profit | $10.40B | $10.37B | $10.52B | $9.04B |
| Gross Profit Ratio | $0.37 | $0.38 | $0.37 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.15B | $5.48B | $5.31B | $5.15B |
| Operating Expenses | $4.77B | $5.04B | $4.91B | $4.77B |
| Total Costs & Expenses | $22.83B | $22.50B | $22.93B | $21.81B |
| Interest Income | $31.40M | $39.02M | $40.17M | $47.46M |
| Interest Expense | $97.12M | $107.87M | $102.42M | $110.56M |
| Depreciation & Amortization | $1.62B | $1.60B | $1.55B | $1.50B |
| EBITDA | $7.30B | $6.99B | $7.22B | $5.82B |
| EBITDA Ratio | $0.26 | $0.26 | $0.26 | $0.23 |
| Operating Income | $5.62B | $5.32B | $5.61B | $4.27B |
| Operating Income Ratio | $0.20 | $0.19 | $0.20 | $0.17 |
| Other Income/Expenses (Net) | -$47.13M | -$43.68M | -$38.33M | -$49.05M |
| Income Before Tax | $5.58B | $5.28B | $5.57B | $4.22B |
| Income Before Tax Ratio | $0.20 | $0.19 | $0.20 | $0.16 |
| Income Tax Expense | $1.08B | $840.60M | $1.15B | $756.08M |
| Net Income | $4.35B | $4.33B | $4.25B | $3.33B |
| Net Income Ratio | $0.15 | $0.16 | $0.15 | $0.13 |
| EPS | $0.27 | $0.27 | $0.27 | $0.21 |
| Diluted EPS | $0.27 | $0.27 | $0.27 | $0.21 |
| Weighted Avg Shares Outstanding | $15.89B | $15.89B | $15.89B | $15.89B |
| Weighted Avg Shares Outstanding (Diluted) | $15.89B | $15.89B | $15.89B | $15.89B |
Over the past four quarters, Bangkok Dusit Medical Services Public Company Limited demonstrated steady revenue growth, increasing from $25.70B in Q2 2024 to $28.08B in Q1 2025. Operating income reached $5.62B in Q1 2025, maintaining a consistent 20% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $7.30B, reflecting operational efficiency. Net income rose to $4.35B, with EPS at $0.27. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan